Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00640445 · ClinicalTrials.gov registry record · Phase 2
Military to Civilian: Trial of an Intervention to Promote Postdeployment Reintegration
A Phase 2 study, sponsored by Minneapolis Veterans Affairs Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,292
- Enrollment target
NCT00640445: Completed Phase 2 study, sponsored by Minneapolis Veterans Affairs Medical Center.
NCT00640445 is a Phase 2 study that has completed, run by Minneapolis Veterans Affairs Medical Center. The registered enrollment target is 1,292 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (871% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00640445, a Phase 2 study, has completed, sponsored by Minneapolis Veterans Affairs Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,292 participants
- Enrollment target
Study Summary
Veterans returning from combat deployments face the interrelated challenges of processing their combat experiences and transitioning back to civilian life. Unfortunately, many veterans wait years or decades before seeking help for post-deployment problems, if they seek it at all. This study seeks to determine whether Internet-Based Expressive Writing (IB-EW), a brief, low-cost, easily disseminated, and resource-efficient intervention, can reduce psychological symptoms and improve functioning among Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF) veterans as they navigate this transition, while also attempting to reduce barriers to help-seeking. Expressive Writing, a highly private, readily accessible, and non-stigmatizing intervention, has a strong evidence-base in civilian populations, but its efficacy in combat veterans has not been tested. This study therefore seeks to test the efficacy of Expressive Writing in a veteran population while further enhancing its accessibility by delivering it over the internet (Internet-Based Expressive Writing; IB-EW). This study will comprise a randomized controlled trial with three conditions: (a) Internet-Based Expressive Writing, (b) Internet-Based Control Writing, and (c) No Writing/Treatment As Usual, with a total of 1152 OIF/OEF veterans randomized across these groups. Expressive Writing participants will write with feeling about their transition from being a soldier to being a civilian; Control Writing participants will write factually about the information needs of new veterans; and Treatment as Usual participants will complete the assessments but not engage in any writing assignments. Participants will complete standardized self-report measures of psychological symptoms, psychosocial functioning, and life satisfaction at baseline (Session 1) and at three months (Session 6) and six months (Session 7) post-intervention. Participants in writing conditions will write for 20 minutes on four consecutive days (
Interventions
- BEHAVIORAL Expressive Writing
- BEHAVIORAL Control Writing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,292 participants |
| Start Date | 2011-06 |
| Est. Completion | 2013-09 |
| Phase | Phase 2 |
What the finished NCT00640445 record still lists
NCT00640445 is an interventional study that assigns participants to a tested intervention. Its 1,292 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (871% higher).
The record links to 0 conditions, and to 2 interventions - of which Expressive Writing is the first listed.
NCT00640445 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00640445 about?
NCT00640445 is a clinical study titled "Military to Civilian: Trial of an Intervention to Promote Postdeployment Reintegration". Veterans returning from combat deployments face the interrelated challenges of processing their combat experiences and transitioning back to civilian life. Unfortunately, many veterans wait years or decades before seeking help for post-deployment problems, if they seek it at all. This study seeks to...
What is the current status of trial NCT00640445?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,292 participants. The study started on 2011-06. Estimated completion is 2013-09.
What interventions are being tested in trial NCT00640445?
The interventions under investigation include: Expressive Writing (BEHAVIORAL), Control Writing (BEHAVIORAL).
Who is sponsoring clinical trial NCT00640445?
This trial is sponsored by Minneapolis Veterans Affairs Medical Center, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00640445's enrollment target sits among peer trials
1,292 13th of 2000 higher than 1,988 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05595642 · 1,290 participants · Phase 3
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
- NCT05812807 · 1,295 participants · Phase 3
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
- NCT04792684 · 1,300 participants
Collection of Samples USOPTIVAL Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia